Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Nebraska
With
National Cancer Institute (NCI)
OBJECTIVES:
* To determine whether early myocardial structural and functional changes can be detected using cardiac MRI in patients with newly diagnosed non-Hodgkin lymphoma or Hodgkin lymphoma receiving doxorubicin hydrochloride-based chemotherapy.
OUTLINE: Patients undergo cardiac MRI with gadolinium contrast prior to initiation of doxorubicin hydrochloride-based chemotherapy and 3 months after completion of six courses of chemotherapy for non-Hodgkin lymphoma and twelve courses of chemotherapy for Hodgkin lymphoma.
Age
19–120
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Diagnosis of non-Hodgkin lymphoma or Hodgkin lymphoma
o Newly diagnosed disease
Planning to receive doxorubicin hydrochloride-based chemotherapy solely at the University of Nebraska Medical Center
